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120 Canine detection of Pseudomonas aeruginosa (PA) volatile
organic compounds (VOC’s)
N.V. Johnston1, J. Rao2, J.S. Elborn3,4, J.E. Moore5. 1Dogs Nose Ltd, Portadown,
United Kingdom; 2University of Ulster, School of Biomedical Sciences, Coleraine,
United Kingdom; 3Queen’s University Belfast, Centre for Infection and Immunity,
Belfast, United Kingdom; 4Belfast City Hospital, Regional Adult Cystic Fibrosis
Centre, Belfast, United Kingdom; 5Belfast City Hospital, Department of
Bacteriology, Belfast, United Kingdom
Objective: To select and professionally train 2 dogs (2 yo foxhound cross and 1
yo retriever cross) using established techniques for the detection of blood, narcotics
and explosives.
Method: Training was given over a 5 month period comprising 54 individual
sessions involving both dogs with PA VOCs from wildtype clinical PA isolate
grown to stationary phase. Dogs were then challenged with control VOCs obtained
from 10 species from seven different genera of bacteria taken from references
strains, including the Gram-positives (Staphylococcus aureus (including MRSA),
S. epidermidis, Bacillus cereus/pumilis/subtilis, Enterococcus faecalis and Listeria
monocytogenes, as well as the Gram-negatives (E. coli, Klebsiella pneumoniae,
Salmonella poona). Ten species of yeasts and fungi were also challenged, taken
from 5 genera including Aspergillus ﬂavus/fumigatus/niger, Candida albicans/
glabrata/krusei/parapsilosis, Exophiala dermatitidis, Penicillium sp. & Scedospo-
rium apiospermum. On successful completion of this stage (non detection of PA),
dogs were further challenged by introducing distractor VOCs ranging from one
through 20 bacterial/fungal species in combination with/without the presence of PA
VOCs.
Conclusion: Overall, the mean speciﬁcity was 96.2%. With 338 challenges, dog
#1 successfully detected PA in all distractor combinations, had 3 false positive
and 0 false negatives, whereas dog #2 had 9 false positive and 1 false-negative
indications. To date, we have not attempted to estimate the sensitivity of detection.
Phase III clinical trials are now being planned to detect PA VOCs directly from
patient sputum and captured breath.
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Introduction: Chronic infection with P. aeruginosa (PA) is common in both CF
and non-CF bronchiectasis not related to CF (BE). Although well characterized in
CF, less is known regarding PA infection in BE. This study aimed to compare PA
isolates from both CF and BE.
Methods: PA from CF [n = 7 Liverpool epidemic strains (LES); n = 8 Belfast
(BFS) isolates] wereas compared to PA from BE (n = 16 isolates from 10 patients).
BE PA isolates obtained pre- (n = 5) and post-antibiotic (n = 5) treatment of a
pulmonary exacerbation were included, together with two distinct PA morphotypes
(n = 6 isolates), from one patient. Isolates were characterized by Pulsed Field Gel
Electrophoresis (PFGE).
Results: PFGE identiﬁed 4 main groups, each with >50% homology: Groups
A (n = 7 NCFB BE PA; n = 1 BFS PA), B (n = 10 BFS PA; n = 3 LES PA), C
(n = 8 NCFBE PA), and D (n = 4 LES PA). Isolates taken pre- and post-antibiotics
in one NCFB BE patient were >70% similar (group A), with the exception
of 1 post-treatment isolate which shared <45% homology (group C). Different
morphotypes isolated from this patient were found to be genotypically identical
(>95% homology).
Conclusions: PA isolates from a BE patient pre- and post-antibiotic treatment were
identical, with one exception. This genotypically distinct isolate may have initially
been below detection limits or may represent a new colonization. In general, PA
from CF and BE formed distinct PFGE groups, suggesting genotypic differences
between isolates from CF and BE. Further numbers of isolates from both diseases
are currently under investigation to conﬁrm this ﬁnding.
122 Comparison of pulsed-ﬁeld gel electrophoresis and DiversiLab
system for typing Pseudomonas aeruginosa in cystic ﬁbrosis
patients
D. Keating1, K. Schaffer1. 1St. Vincents University Hospital, Dublin, Ireland
Molecular typing of Pseudomonas aeruginosa (P. aeruginosa) in cystic ﬁbrosis (CF)
patients is important to monitor for evidence of cross-infection in this cohort of
patients. Pulsed ﬁeld gel eelectrophoresis (PFGE) has long been the gold standard
method for typing, although problems with standardisation, reproducibility and the
laborious nature of the technique has led to the development of sequenced based
methods such as multi-locus sequence typing (MLST). While MLST has been
shown to be more reproducible and can be compared between centres, it is still
quite expensive and requires specialised equipment and trained staff.
Objective: In this study, we examined the use of the DiversiLab typing system,
which is based on a patented rep-PCR method for typing of P. aeruginosa isolates.
Methods: The Diversilab typing system consists of three parts: isolation of DNA,
Ampliﬁcation of the isolated DNA with rep-PCR and detection of the ampliﬁed
material using chip electrophoresis. P. aeruginosa isolates isolated from CF patients
were typed in parallel using PFGE and Diversilab.
Results: Preliminary analysis of 12 P. aeruginosa isolates by both methods revealed
similar typing patterns in 84% of isolates and divergent results in 16% of isolates.
Conclusions: The DiversiLab typing system is more rapid and user friendly than
PFGE. Preliminary analysis suggests that the discrimination of P. aeruginosa strains
by DiversiLab is lower than by PFGE. Analysis of additional isolates will determine
the true discriminatory power and reproducibility of the DiversiLab system for CF
P. aeruginosa isolates.
123 Prevalence of transmissible strains of Pseudomonas aeruginosa
in a cystic ﬁbrosis tertiary referral centre and lung transplant unit
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Background: For cystic ﬁbrosis (CF) patients colonised with transmissible strains
of P. aeruginosa, in particular the Liverpool epidemic strain (LES), the requirement
for lung transplantation or the 3-year rate of death has been reported as being greater
than for those colonised with non transmissible strains. We examined a collection
of P. aeruginosa from CF patients either assessed for transplantation or transplanted
at our centre and from patients attending our CF unit to determine the prevalence
of transmissible strains.
Method: Species-speciﬁc PCR was used to detect genetic markers for the LES,
Manchester and Midlands epidemic strains from 86 CF patients in the transplant
group and a combination of species-speciﬁc PCR, variable number tandem repeats
and pulse ﬁeld electrophoresis on single isolates from 169 CF patients attending
our CF unit.
Results: Of the 169 isolates from patients attending our CF unit, 5.3% were
colonised with the Manchester strain, 4.8% with the LES and 3.5% clone C.
From the lung transplant group 6 isolates were identiﬁed as the LES and 2 as the
Manchester strain. Three of six patients colonised with the LES strain underwent
successful lung transplantation, the remaining three patients died pre-transplant.
One of two patients colonised with the Manchester strain died post transplant. This
was not attributed to Pseudomonas infection, the second patient died pre-transplant
Summary: A small number of patients attending our CF unit are colonised
with transmissible strains of P. aeruginosa. Our limited data demonstrates lung
transplantation for CF patients colonised with LES has good outcomes.
